CARLA ROBERTSON: Open Payments
NPI 1891345567 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$370 in 21 payments from 7 companies in 2025. Trend: 2023 $208 · 2024 $220 · 2025 $370
Food & beverage: $370
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $203 |
| AstraZeneca Pharmaceuticals LP | 3 | $61 |
| PFIZER INC. | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Genentech USA, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
Products named: Ozempic, Rybelsus, AIRSUPRA, Wegovy, PREVNAR 20, TRELEGY ELLIPTA, GVOKE HYPOPEN, Xolair.
Industry payments across FL — which companies pay providers there.
